Bank of New York Mellon’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.3M | Buy |
668,814
+149,947
| +29% | +$292K | ﹤0.01% | 2961 |
|
|
2025
Q1 | $913K | Buy |
518,867
+292
| +0.1% | +$514 | ﹤0.01% | 3104 |
|
|
2024
Q4 | $1.38M | Buy |
518,575
+14,203
| +3% | +$37.8K | ﹤0.01% | 2935 |
|
|
2024
Q3 | $1.16M | Sell |
504,372
-122,533
| -20% | -$281K | ﹤0.01% | 3055 |
|
|
2024
Q2 | $1.83M | Buy |
626,905
+157,511
| +34% | +$460K | ﹤0.01% | 2835 |
|
|
2024
Q1 | $1.71M | Sell |
469,394
-48,710
| -9% | -$177K | ﹤0.01% | 2846 |
|
|
2023
Q4 | $782K | Buy |
518,104
+1,500
| +0.3% | +$2.27K | ﹤0.01% | 3314 |
|
|
2023
Q3 | $692K | Buy |
516,604
+217
| +0% | +$291 | ﹤0.01% | 3376 |
|
|
2023
Q2 | $929K | Buy |
516,387
+61,228
| +13% | +$110K | ﹤0.01% | 3227 |
|
|
2023
Q1 | $756K | Sell |
455,159
-14,201
| -3% | -$23.6K | ﹤0.01% | 3262 |
|
|
2022
Q4 | $901K | Buy |
469,360
+28,837
| +7% | +$55.4K | ﹤0.01% | 3242 |
|
|
2022
Q3 | $987K | Buy |
440,523
+40,055
| +10% | +$89.7K | ﹤0.01% | 3207 |
|
|
2022
Q2 | $1.3M | Sell |
400,468
-90,903
| -18% | -$294K | ﹤0.01% | 3072 |
|
|
2022
Q1 | $2.58M | Buy |
491,371
+503
| +0.1% | +$2.65K | ﹤0.01% | 2795 |
|
|
2021
Q4 | $4.17M | Buy |
490,868
+207,498
| +73% | +$1.76M | ﹤0.01% | 2557 |
|
|
2021
Q3 | $2.82M | Buy |
283,370
+134,797
| +91% | +$1.34M | ﹤0.01% | 2795 |
|
|
2021
Q2 | $1.38M | Buy |
148,573
+124,453
| +516% | +$1.16M | ﹤0.01% | 3222 |
|
|
2021
Q1 | $252K | Buy |
+24,120
| New | +$252K | ﹤0.01% | 3971 |
|